• If you are trying to work out whether Axon Enterprise at around US$447 per share is priced for perfection or still offers value, the next sections walk through what the current numbers actually say.
• The stock has been volatile recently, with a decline of 7% over the past week and a gain of 13.5% over the past month. It remains down 20.6% year to date and down 42.5% over the last year, while still sitting on a 126.3% gain over three years and 194.5% over five years.
• Recent coverage has focused on how Axon Enterprise fits into broader themes in public safety technology and investor interest in companies serving law enforcement and related agencies. This context has helped shape views on both its long term potential and the risks investors are weighing as the share price moves.
• Against this backdrop, Axon Enterprise currently records a valuation score of 1 out of 6. The sections ahead will compare different valuation approaches for the stock and then finish with a framework that can help you think about value in a more complete way.

Axon Enterprise scores just 1/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

Approach 1: Axon Enterprise Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model estimates what a stock could be worth by projecting the company’s future cash flows and then discounting them back to today’s value. It is essentially asking what those future dollars are worth in today’s terms.

For Axon Enterprise, the model used is a 2 Stage Free Cash Flow to Equity approach based on cash flow projections. The latest twelve month free cash flow is about $28.7m. Analyst estimates and subsequent extrapolations point to free cash flow of $1,001.2m in 2028, with additional projections running out to 2035, all expressed in $.

After discounting these projected cash flows, the model arrives at an estimated intrinsic value of about $386.24 per share. Compared with the recent share price around $447, the DCF output suggests the stock is priced about 15.9% above this intrinsic value, which indicates it screens as overvalued on this metric alone.

Result: OVERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Axon Enterprise may be overvalued by 15.9%. Discover 48 high quality undervalued stocks or create your own screener to find better value opportunities.

Approach 2: Axon Enterprise Price vs Sales

For profitable companies that are still heavily focused on scaling revenue, the P/S ratio can be a useful cross check because it compares what you pay for each dollar of sales, regardless of how accounting profits look in any single year.

In general, higher expected growth and lower perceived risk can justify a higher P/S ratio, while lower growth expectations or higher risk usually line up with a lower, more conservative multiple.

Axon Enterprise currently trades on a P/S of 12.09x. That is above the Aerospace & Defense industry average of 5.54x and also ahead of the peer group average of 6.79x, so on simple comparisons the stock screens as expensive.

Simply Wall St’s Fair Ratio is a proprietary estimate of what a reasonable P/S might be for Axon Enterprise, based on factors such as its growth profile, industry, profit margins, market value and risk characteristics. This makes it a more tailored yardstick than a broad industry or peer average, which do not adjust for these company specific traits.

On this framework, Axon Enterprise’s Fair Ratio is 15.44x, above the current 12.09x P/S. This indicates that on this metric the stock screens as undervalued.

Result: UNDERVALUED

Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.

Upgrade Your Decision Making: Choose your Axon Enterprise Narrative

Earlier it was mentioned that there is an even better way to think about valuation. On Simply Wall St that starts with Narratives, where you choose a clear story for Axon Enterprise, translate that story into assumptions for revenue, earnings and margins, and the platform turns it into a fair value you can compare with the current share price to help decide whether the stock looks attractively or richly priced.

A Narrative is simply your view of what Axon Enterprise really is, such as a hardware focused TASER business or a public safety software and data platform. It is linked directly to a forecast and a fair value number, instead of sitting separately from the financials.

On the Simply Wall St Community page, Narratives are set up so you can pick or adjust a storyline, see how that maps into things like revenue growth, profit margins, discount rates and P/E assumptions, and then instantly see the resulting fair value alongside the latest market price.

For Axon Enterprise, one investor might build a bullish Narrative with a fair value around US$925, based on strong recurring revenue and AI driven products. Another might prefer a more cautious Narrative closer to US$420. As new data, news or earnings arrive, these Narratives update automatically so you can see how your story and fair value change over time.

For Axon Enterprise, we will make it really easy for you with previews of two leading Axon Enterprise Narratives:

Fair value in this bullish Narrative: about US$662.04 per share.

At the recent price of about US$447.59, this Narrative implies the stock is around 32.4% below that fair value estimate.

Revenue growth assumption: 28.14% a year.

• Focuses on Axon as an AI enabled public safety platform with growing recurring SaaS revenue, supported by products such as Draft One, TASER 10, Axon Body 4 and Dedrone.
• Assumes international expansion and higher value bundles broaden the addressable market and support higher margins over time.
• Highlights risks around reliance on government budgets, regulation, competition, international execution and cost pressures, but still supports an analyst consensus target of about US$662.

Fair value in this more cautious Narrative: about US$420.19 per share.

At the recent price of about US$447.59, this Narrative implies the stock is around 6.1% above that fair value estimate.

Revenue growth assumption: 26.73% a year.

• Emphasises risks from commoditisation of AI hardware and software, tighter data privacy rules and higher compliance costs that could pressure margins.
• Frames Axon’s reliance on government contracts and procurement cycles as a key source of revenue and earnings volatility, especially if funding priorities shift.
• Anchors on a bearish fair value of about US$420, based on lower margin assumptions, sector multiple compression and a higher P/E requirement to justify long term earnings forecasts.

These two Narratives bracket a wide range of potential outcomes around Axon Enterprise. The next step is to decide which story, or blend of stories, aligns more closely with how you see the business, its risks and the price you are willing to pay for that exposure.

Do you think there's more to the story for Axon Enterprise? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.